Targeting chemotherapy to advanced bladder cancer patients most likely to benefit

By Catto James WF   Hamdy Freddie C  

Future Oncology, Vol. 6, Iss. 2, 2010-02 ,pp. : 193-196

Future Medicine

Access to resources Recommend Favorite

Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy

By Kim Ki  

Gastric Cancer, Vol. 14, Iss. 2, 2011-06 ,pp. : 130-138

Springer Publishing Company

Access to resources Recommend Favorite

Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer

By Murakami Michiyasu   Hashimoto Hiroki   Yamaguchi Kyohei   Yamaguchi Ikuko   Senba Shozo   Siraishi Takeshi  

Supportive Care in Cancer, Vol. 22, Iss. 4, 2014-04 ,pp. : 905-909

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of Intensive Adjuvant Chemotherapy in Gastric Cancer Using Life Expectancy Compared with Log-Rank Test as a Measure of Survival Benefit

By Nishikawa Toshikuni   Maetani Shunzo  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 348-354

Springer Publishing Company

Access to resources Recommend Favorite

Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice

By Rossi Luigi   Veltri Enzo   Zullo Angelo   Zoratto Federica   Colonna Maria   Di Seri Marisa   Longo Flavia   Mottolese Marcella   Giannarelli Diana   Ruco Luigi   Romiti Adriana   Barucca Viola   Adua Daniela   Tomao Silverio  

Future Oncology, Vol. 8, Iss. 9, 2012-09 ,pp. : 1193-1197

Future Medicine

Access to resources Recommend Favorite